Detail akcie InterCure Rg online

Business Summary: InterCure Ltd is an Israel-based medical device company. It is engaged in the production and sale of RESPeRATE, a Food and Drug Administration approved, non-drug, non-invasive hypertension treatment device. The Company’s patented device-guided breathing platform is used by RESPeRATE, and it enables a systematic reduction in sympathetic outflow of the autonomous nervous system, one of the key underlining causes for cardiovascular disease, insomnia and multiple other conditions. The Company operates a marketing office in London and outsourced call centers and warehouses in the United States, the United Kingdom, Germany and Canada.
Financial Summary: BRIEF: For the six months ended 30 June 2021, InterCure Ltdrevenues increased from NIS15.4M to NIS78.3M. Net incometotaled NIS9.4M vs. loss of NIS48.2M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net Income reflectsBiomed Segment income totaling NIS326K vs. loss of NIS39.3M, Cannabis Segment income increase from NIS241K to NIS18.7M.